Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney

D O Dahle1,2, A Åsberg1,3,4, A Hartmann1,2

  • 1Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway.

Insights

Calcification propensity, measured by T50, is linked to higher mortality in kidney transplant recipients. This blood test may offer new insights into cardiovascular risks post-transplant.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Vascular calcification is a significant risk factor for cardiovascular disease and mortality in kidney transplant recipients.
  • A novel blood test, measuring calcification propensity via calciprotein particle transformation time (T50), offers a new metric for assessing this risk.

Purpose of the Study:

  • To investigate the association between calcification propensity (T50) and mortality in kidney transplant recipients.
  • To explore the relationship between T50 and aortic pulse wave velocity (APWV) in this patient cohort.

Main Methods:

  • T50 was measured in 1435 kidney transplant recipients across two eras (2000-2003 and 2009-2012).
  • APWV was assessed in 589 patients from the second era at baseline and 1-year follow-up.
  • Cox regression models were used to analyze the association between T50 and mortality over a median follow-up of 5.1 years.

Main Results:

  • Accelerated T50 was associated with factors including diabetes, deceased donor, first transplant, rejection, and higher serum phosphate.
  • T50 was not significantly associated with the progression of APWV.
  • Accelerated T50 was independently associated with increased all-cause mortality (HR 1.60) and cardiac mortality (HR 3.60).

Conclusions:

  • Calcification propensity, as measured by T50, is a strong independent predictor of both all-cause and cardiac mortality in kidney transplant recipients.
  • The findings suggest a potential cardiac pathway independent of APWV, highlighting T50 as a critical biomarker.
  • Further randomized trials are needed to determine if therapeutic interventions targeting T50 can improve patient outcomes.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
707
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
856
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
308
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
964
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
623
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
627